Endocrine Abstracts

Background: Cushing’s syndrome (CS) is a relatively unusual condition that resembles many of the phenotypic features of obesity. The 1-mg dexamethasone suppression test (1 mg-DST) is the most frequently used screening tool for CS. However, the lack of suppression after 1-mg DST may be found in obese patients. In the current study, our aim was to evaluate the clinical signs of CS and the 1 mg-DST in obese patients.Materials and methods: 354 patients ...